J&J pays Sail $785M, charting course to possible in vivo CAR-T buyout Read more →
Sanofi’s new CEO ‘looking deeply’ at late-stage pipeline as clinical clearout continues Read more →
FDA adcomm shoots down Capricor's Duchenne cell therapy after meeting marked by statistical dispute Read more →
